Brandon J Webb
Overview
Explore the profile of Brandon J Webb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Molina K, Webb B, Kennerley V, Beaty L, Bennett T, Carlson N, et al.
BMC Infect Dis
. 2024 Aug;
24(1):802.
PMID: 39118052
Background: A trial performed among unvaccinated, high-risk outpatients with COVID-19 during the delta period showed remdesivir reduced hospitalization. We used our real-world data platform to determine the effectiveness of remdesivir...
3.
Veillette J, May S, Alzaidi S, Olson J, Butler A, Waters C, et al.
Open Forum Infect Dis
. 2024 Apr;
11(4):ofae193.
PMID: 38665174
Background: Robust data are lacking regarding the optimal route, duration, and antibiotic choice for gram-negative bloodstream infection from a complicated urinary tract infection source (GN-BSI/cUTI). Methods: In this multicenter observational...
4.
Aggarwal N, Beaty L, Bennett T, Fish L, Jacobs J, Mayer D, et al.
Lancet Reg Health Am
. 2024 Mar;
31:100693.
PMID: 38500962
Background: Ritonavir-boosted Nirmatrelvir (NMV-r), a protease inhibitor with activity against SARS-CoV-2, can reduce risk of progression to severe COVID-19 among high-risk individuals infected with earlier variants, but less is known...
5.
Alzaidi S, Veillette J, May S, Olson J, Jackson K, Waters C, et al.
Open Forum Infect Dis
. 2024 Feb;
11(2):ofad657.
PMID: 38370295
Background: Fluoroquinolones (FQs) are effective for oral step-down therapy for gram-negative bloodstream infections but are associated with unfavorable toxic effects. Robust data are lacking for trimethoprim-sulfamethoxazole (TMP-SMX) and high-bioavailability β-lactams...
6.
May S, Veillette J, Webb B, Stenehjem E, Throneberry S, Gelman S, et al.
J Hosp Med
. 2023 May;
18(8):719-723.
PMID: 37127939
Antibiotic stewardship interventions are urgently needed to reduce antibiotic overuse in hospitalized COVID-19 patients, particularly in small community hospitals (SCHs), who often lack access to infectious diseases (ID) and stewardship...
7.
Hooper G, Klippel C, McLean S, Stenehjem E, Webb B, Murnin E, et al.
Clin Infect Dis
. 2023 Feb;
76(12):2047-2055.
PMID: 36806551
Background: Guidelines emphasize rapid antibiotic treatment for sepsis, but infection presence is often uncertain at initial presentation. We investigated the incidence and drivers of false-positive presumptive infection diagnosis among emergency...
8.
Veillette J, May S, Gabrellas A, Gelman S, Albritton J, Lyons M, et al.
Open Forum Infect Dis
. 2022 Nov;
9(11):ofac549.
PMID: 36381624
Background: Infectious diseases (ID) and antimicrobial stewardship (AS) improve bacteremia (SAB) outcomes. However, many small community hospitals (SCHs) lack on-site access to these services, and it is not known if...
9.
Tinker N, Foster R, Webb B, Haydoura S, Buckel W, Stenehjem E
Antimicrob Steward Healthc Epidemiol
. 2022 Sep;
1(1):e46.
PMID: 36168471
Developing and improving an antimicrobial stewardship program successfully requires evaluation of numerous factors. As technology progresses and our understanding of antimicrobial resistance grows, careful consideration should be taken to ensure...
10.
Horne B, Bledsoe J, Muhlestein J, May H, Peltan I, Webb B, et al.
BMJ Open
. 2022 Mar;
12(3):e053864.
PMID: 35332038
Objectives: The Intermountain Risk Score (IMRS), composed using published sex-specific weightings of parameters in the complete blood count (CBC) and basic metabolic profile (BMP), is a validated predictor of mortality....